HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth has reaffirmed a Buy rating on Ekso Bionics Holdings (NASDAQ:EKSO) and increased the price target from $9 to $10.

January 22, 2024 | 6:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Ekso Bionics Holdings and raises the price target from $9 to $10.
The reaffirmation of a Buy rating coupled with an increased price target typically signals analyst confidence in the company's future performance, which can positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100